Product Commercialization

Expand into global markets faster with culturally relevant and compliant messaging. Choose centralized content solutions that ensure native-level localized translation, meet varied regulatory requirements on a region-by-region basis, and increase your speed to global launch.

Get in Touch
Person using iPad to analyze metrics

Comprehensive Support for Product Launches and Commercialization Plans

By partnering with TransPerfect, your team will increase preparation efficiency and shorten time to launch. Discover our complete suite of global product launch solutions.

    Digital Marketing

    Obtain strategic guidance on your omnichannel digital marketing efforts and website localization with our TPT Digital solution. Drive visibility to global marketing campaigns and create targeted messaging for your commercialization plan based on the customer journey.

    Learn More

    Translation Services

    We offer powerful technology to enable faster, more accurate translations of your product launch collateral such as app, website, brochure, and e-learning materials. TransPerfect’s GlobalLink TMS automates manual steps, drives consistency through central TMs and linguistic assets, incorporates MT workflows, and offers real-time reporting for greater visibility and control.

    Learn More

    Social Listening

    Meet with experts to review keyword requirements, search terms, and translations. TransPerfect centralizes the review of literature and streamlines the monitoring of all major social channels to understand the global sentiment around your brand.

    Learn More

    Multicultural Marketing Consulting

    Work with TransPerfect’s cultural consultants to identify your target market, how to best adapt existing marketing content, and create original content and materials that will produce the desired results.

    Learn More

    Trusted by Life Sciences Organizations Big and Small

    With TransPerfect’s support, Novartis, Pfizer, and Merck have created an average of more than $5M in savings. Partnering with TransPerfect has significantly reduced their product localization costs and made it possible for their products to launch up to 50% faster than the competition.

    Novartis
    Pfizer logo
    Merck
    Get a Free Consult ›

    Better Product Commercialization Launches by the Numbers

    30 %

    Faster Product Launch Times

    100 %

    Regulatory Compliance

    $ 5 M

    Average Saved by Novartis, Pfizer, and Merck in Product Localization

    Ready to accelerate your product launch and commercialization?

    Get in Touch ›

    News and Thought Leadership

    View industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexities and bring breakthroughs from lab to launch.

    Governing AI for Global Content in the Life Sciences Industry

    AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and patient trust at risk. This guide lays out a practical operating model for governed AI in life sciences: measure quality across every language, route content by risk, and build the audit ...

    Governing AI for Global Content in the Life Sciences Industry
    Webinar

    Reddit Stories: AI Failures in Clinical Trials

    Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...
    Blog

    Are Legacy COA Instruments Still Fit for Purpose?

    The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....
    Webinar

    The Human in the Vault: Building Review Workflows That Satisfy Regulators

    AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process ...
    Blog

    eConsent: Why the Content Matters as Much as the Tech

    Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind...
    Guide

    Pragmatic Use Cases for AI in Medical Information

    The rapid advancement of AI presents medical information teams with powerful new opportunities to transform their operations. From inquiry intake and intelligent triage to case management and standard response development, AI-driven solutions are already delivering measurable ...
    Webinar

    LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients

    Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, ...